{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T05:15:10Z","timestamp":1773465310741,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"25","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,4]],"date-time":"2018-05-04T00:00:00Z","timestamp":1525392000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.vaccine.2018.05.023","type":"journal-article","created":{"date-parts":[[2018,5,8]],"date-time":"2018-05-08T19:16:26Z","timestamp":1525806986000},"page":"3674-3680","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Safety of a heat-stable rotavirus vaccine among children in Niger: Data from a phase 3, randomized, double-blind, placebo-controlled trial"],"prefix":"10.1016","volume":"36","author":[{"given":"Matthew E.","family":"Coldiron","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ousmane","family":"Guindo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rockyath","family":"Makarimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Issaka","family":"Soumana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amadou","family":"Matar Seck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Souna","family":"Garba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilie","family":"Macher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheila","family":"Isanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca F.","family":"Grais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.05.023_b0005","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S1473-3099(11)70253-5","article-title":"2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis","volume":"12","author":"Tate","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2018.05.023_b0010","doi-asserted-by":"crossref","first-page":"573","DOI":"10.3201\/eid2004.131328","article-title":"Rotavirus surveillance in urban and rural areas of Niger, April 2010-March 2012","volume":"20","author":"Page","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2018.05.023_b0015","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1016\/j.vaccine.2015.03.016","article-title":"Effectiveness and impact of rotavirus vaccines in Europe, 2006\u20132014","volume":"33","author":"Karafillakis","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.05.023_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2017.10.060","article-title":"Early impact of rotavirus vaccination in children less than five years of age in Mozambique","author":"de Deus","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.05.023_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2017.12.056","article-title":"Impact and effectiveness of pentavalent rotavirus vaccine in children","author":"Bonkoungou","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.05.023_b0030","article-title":"Cost-effectiveness of rotavirus vaccination in Ghana: examining impacts from 2012 to 2031","volume":"2017","author":"Nonvignon","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.05.023_b0035","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1586\/erv.09.106","article-title":"Intussusception and rotavirus vaccination: a review of the available evidence","volume":"8","author":"Patel","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2018.05.023_b0040","first-page":"53","article-title":"Global Advisory committee on vaccine safety, December 2011","volume":"87","author":"World Health Organization","year":"2012","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2018.05.023_b0045","unstructured":"Weekly epidemiological record Relev\u00e9 \u00e9pid\u00e9miologique hebdomadaire 2014;89:53\u201360."},{"key":"10.1016\/j.vaccine.2018.05.023_b0050","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1016\/j.vaccine.2017.04.025","article-title":"Stability of heat stable, live attenuated Rotavirus vaccine (ROTASIIL\u00ae)","volume":"35","author":"Naik","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.05.023_b0055","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJMoa1609462","article-title":"Efficacy of a low-cost, heat-stable oral rotavirus vaccine in niger","volume":"376","author":"Isanaka","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2018.05.023_b0060","unstructured":"Niger | Data n.d. <https:\/\/data.worldbank.org\/country\/niger> [accessed December 14, 2017]."},{"key":"10.1016\/j.vaccine.2018.05.023_b0065","doi-asserted-by":"crossref","unstructured":"GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017;390:1151\u2013210. 10.1016\/S0140-6736(17)32152-9.","DOI":"10.1016\/S0140-6736(17)32152-9"},{"key":"10.1016\/j.vaccine.2018.05.023_b0070","unstructured":"Council for International Organizations of Medical Sciences. Guidelines for preparing core clinical safety information on drug from CIOMS Working Group III; 1995."},{"key":"10.1016\/j.vaccine.2018.05.023_b0075","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0264-410X(02)00449-8","article-title":"The Brighton Collaboration: addressing the need for standardized case definitions of adverse events following immunization (AEFI)","volume":"21","author":"Bonhoeffer","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.05.023_b0080","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0264-410X(03)00511-5","article-title":"Standardized case definitions of adverse events following immunization (AEFI)","volume":"22","author":"Bonhoeffer","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.05.023_b0085","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/00005176-200411000-00012","article-title":"Clinical case definition for the diagnosis of acute intussusception","volume":"39","author":"Bines","year":"2004","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.vaccine.2018.05.023_b0090","unstructured":"World Health Organization. Post-marketing surveillance of rotavirus vaccine safety. Geneva: n.d."},{"key":"10.1016\/j.vaccine.2018.05.023_b0095","unstructured":"World Health Organization. Manual for the training of interviewers on the use of the 2016 WHO VA instrument. Geneva;2017."},{"key":"10.1016\/j.vaccine.2018.05.023_b0100","unstructured":"CIOMS. Management of safety information from clinical trials. Geneva: Council for International Organizations of Medical Sciences; 2005."},{"key":"10.1016\/j.vaccine.2018.05.023_b0105","doi-asserted-by":"crossref","unstructured":"Amouzou A, Habi DESS-ASAD O, Bensa\u00efd MPH K. Niger Countdown Case Study Working Group the. Reduction in child mortality in Niger: a Countdown to 2015 country case study. Lancet 2012;380:1169\u201378. 10.1016\/S0140-6736(12)61376-2.","DOI":"10.1016\/S0140-6736(12)61376-2"},{"issue":"Suppl","key":"10.1016\/j.vaccine.2018.05.023_b0110","doi-asserted-by":"crossref","first-page":"S282","DOI":"10.1086\/605051","article-title":"Assessment of postlicensure safety of rotavirus vaccines, with emphasis on intussusception","volume":"200","author":"Bines","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.05.023_b0115","doi-asserted-by":"crossref","first-page":"6228","DOI":"10.1016\/j.vaccine.2017.09.014","article-title":"A randomized Phase III clinical trial to assess the efficacy of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants","volume":"35","author":"Kulkarni","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.05.023_b0120","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1056\/NEJMoa0904797","article-title":"Effect of human rotavirus vaccine on severe diarrhea in African infants","volume":"362","author":"Madhi","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2018.05.023_b0125","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/infdis\/jit174","article-title":"Efficacy, immunogenicity, and safety of two doses of a tetravalent rotavirus vaccine RRV-TV in Ghana with the first dose administered during the neonatal period","volume":"208","author":"Armah","year":"2013","journal-title":"J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18306303?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18306303?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,21]],"date-time":"2018-08-21T18:23:37Z","timestamp":1534875817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18306303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":25,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0264410X18306303"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.05.023","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety of a heat-stable rotavirus vaccine among children in Niger: Data from a phase 3, randomized, double-blind, placebo-controlled trial","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.05.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}